ABC  Vol.4 No.5 , August 2014
Spin-Labelled 1-Ethyl-1-Nitrosourea Prevents Doxorubicin and Bleomycin-Induced Oxidative Stress in Lungs, Hearts and Kidneys of Tumour-Bearing Mice
Abstract: This study was carried out to determine the possible protective effect of 1-ethyl-3-[4-(2, 2, 6, 6-tetramethylpiperidine-1-oxyl)]-1-nitrosourea (SLENU), recently synthesised in our laboratory on doxorubicin and bleomycin-induced oxidative toxicity in C57 black tumour-bearing mice. Specifically, alterations in some biomarkers of oxidative stress, such as lipid peroxidation products measured as malondialdehyde (MDA) levels and activities of the antioxidant enzymes, superoxide dismutase (SOD) and catalase (CAT), were studied in lung, heart and kidney homogenates isolated from C57 black tumor-bearing mice after i.p. treatment with solutions of DOX (60 mg/kg) and BLM (60 mg/kg). The same biomarkers were also measured after i.p. pretreatment of mice with SLENU (100 mg/kg). After treatment with doxorubicin, heart and kidney homogenates of mice had significantly higher productions of lipid peroxidation compared to lung homogenates. It was accompanied by increased activity of the antioxidant defence enzyme superoxide dismutase and decreased activity of catalase. Bleomycin-induced oxidative stress was confirmed by significantly higher production of lipid peroxidation in lungs compared to heart homogenates, elevation of the anti-oxidant activity of superoxide dismutase and decreased activity of catalase enzymes. After pre-treatment of the mice with SLENU, the levels of all studied oxidative stress biomarkers were significantly improved in comparison with those of the mice treated alone with either bleomycin, or doxorubicin. The present results and those from a previously demonstrated superoxide scavenging activities (SSA) of the nitrosourea SLENU have enabled us to explain the protective effect of the spin-labelled nitrosourea on doxorubicin and bleomycin-induced oxidative stress by scavenging of  O2- and increased NO release.
Cite this paper: Gadjeva, V. , Nikolova, G. , Grigorov, B. , Zheleva, A. , Tolekova, A. and Vasileva, M. (2014) Spin-Labelled 1-Ethyl-1-Nitrosourea Prevents Doxorubicin and Bleomycin-Induced Oxidative Stress in Lungs, Hearts and Kidneys of Tumour-Bearing Mice. Advances in Biological Chemistry, 4, 291-300. doi: 10.4236/abc.2014.45035.

[1]   Singal, P.K. and Iliskovic, N. (1998) Doxorubicin Induced cardiomyopathy. The New England Journal of Medicine, 339, 900-905.

[2]   Kalender, Y., Yel, M. and Kalender, S. (2005) Doxorubicin Hepatotoxicity and Hepatic Free Radical Metabolism in Rats. The Effects of Vitamin E and Catechin. Toxicology, 209, 39-45.

[3]   Yagmurca, M., Bas, O., Mollaoglu, H., Sahin, O., Nacar, A. and Karaman, O. (2007) Protectiveeffects of Erdosteine on Doxorubicin-Induced Hepatotoxicity in Rats. Archives of Medical Research, 38, 380-385.

[4]   Luna, M.A., Bedrossian, C.W., Lichtiger, B. and Salem, P.A. (1972) Interstitial Pneumonitis Associated with Bleomycin Therapy. American Journal of Clinical Pathology, 58, 501-510.

[5]   Szapiel, S.V., Elson, N.A., Fulmer, J.D., Hunninghake, G.W. and Crystal, R.G. (1979) Bleomycin-Induced Interstitial Pulmonary Disease in the Nude, Athymic Mouse. The American Review of Respiratory Disease, 120, 893-899.

[6]   Gutteridge, J.M. and Xiao Change, F. (1981) Protection of Iron Catalysedthe Radical Damage to DNA and Lipids by Copper (II) Bleomycin. Biochemical and Biophysical Research Communications, 99, 1354-1360.

[7]   Filderman, A.E., Genovese, L.A. and Lazo, J.S. (1988) Alterations in Pulmonaryprotective Enzymes Following Systemic Bleomycin Treatment in Mice. Biochemical Pharmacology, 37, 1111-1116.

[8]   Teixeira, K.C., Soares, F.S., Rocha, L.G., Silveira, P.C., Silva, L.A., Valença, S.S., Dal Pizzol, D.F., Streck, E.L. and Pinho, R.A. (2008) Attenuation of Bleomycin-Induced Lung Injury and Oxidative Stress by N-Acetylcysteine Plus Deferoxamine. Pulmonary Pharmacology & Therapeutics, 21, 309-316.

[9]   Raikov, Z., Todorov, D. and Ilarionova, M. (1985) Synthesis and Study of Spin-Labeled Nitrosoureas. Cancer Biochemistry Biophysics, 4, 343-348,

[10]   Gnewuch, C.T. and Sosnovsky, G. (1997) A Critical Appraisal of the Evolution of N-Nitrosoureas as Anticancer Drugs. Chemical Reviews, 97, 829-1013.

[11]   Zheleva, A., Raikov, Z., Ilarionova, M., Carpenter, B., Todorov, D. and Armstrong, N. (1996) Potential Antimelanomic Drugs: I. Synthesis and Antimelanomic Effect of a Spin Labelled D, L-Amino Acid Containing a 2-Chloro-ethylnitrosocarbamoyl Group. Pharmazie, 51, 602-604.

[12]   Gadjeva, V. and Raikov, Z. (1999) Syntheses and Antitumor Activity of 4-{N’-[N-(2-Chloroethyl)-N-Nitrosocarbamoyl]Hydrazono}-2,2,6,6-Tetramethylpiperidine-1-Oxyl. Die Pharmazie, 54, 231-232.

[13]   Gadjeva, V. and Koldamova, R. (2001) Spin-Labeled 1-Alkyl-1-Nitrosourea Synergists of Antitumor Antibiotics. Anti-cancer Drug Design, 16, 247-253.

[14]   Gadjeva, V., Zheleva, A., Lazarova, G. (2003) Spin Labeled Antioxidants Protect Bacteria against the Toxicity of Alkylating Antitumor Drug CCNU. Toxicology Letters, 144, 289-294.

[15]   Gadzheva, V., Ichimory, K., Nakazawa, H. and Raikov, Z. (1994) Superoxide Scavenging Activity of Spin-Labeled Nitrosourea and Triazene Derivatives. Free Radical Research, 21, 177-186.

[16]   Gadjeva, V.D., Kuchukova, D., Tolekova, A. and Tanchev, S. (2005) Beneficial Effects of Spin-Labelled Nitrosourea on CCNU-Induced Oxidative Stress in Rat Blood Compared with Vitamin E. Die Pharmazie, 60, 530-532.

[17]   Gadjeva, V., Tolekova, A. and Vasileva, M. (2007) Effect of the Spinlabelled 1-Ethyl-1-Nitrosourea on CCNU-Induced Oxidative Liver Injury. Pharmazie, 62, 608-613.

[18]   Gadjeva, V., Grigorov, B., Nikolova, G., Tolekova, A., Zheleva, A. and Vasileva, M. (2013) Protective Effect of Spin-Labeled 1-Ethyl-1-Nitrosourea against Oxidative Stress in Liver Induced by Antitumor Drugs and Radiation. BioMed Research International, 2013, Article ID: 924870.

[19]   Geran, R.S., Greenberg, N.H., Macdonald, M.M., Schumacher, A.M. and Abbott, B.J. (1972) Protocols for Screening Chemical Agents and Natural Products against Animal Tumors and Other Biological Systems. Cancer Chemotherapy Reports, 13, 1-87.

[20]   White, B.A., Erickson, M.M. and Stevens, S.C. (1970) Chemistry for Medical Technologists. Mosby, Saint Louis.

[21]   Draper, H.H. and Hadley, M. (1990) Malondialdehyde Determination as an Index of Lipid Peroxidation. Methods in Enzymology, 186, 421-431.

[22]   Sun, Y., Oberley, L.W. and Li, Y. (1988) A Simple Method for Clinical Assay of Superoxide Dismutase. Clinical Chemistry, 34, 497-500.

[23]   Beers, R. and Sizer, T. (1952) Spectrophotometric Method for Measuring the Breakdown of Hydrogenperoxide by Catalase. Journal of Biological Chemistry, 195, 133-138.

[24]   Miranda, K.M., Espey, M.G. and Wink, D.A. (2001) A Rapid, Simples Pectrophotometric Method for Simultaneous Detection of Nitrate and Nitrite. Nitric Oxide, 5, 62-71.

[25]   Dalloz, F., Maingon, P., Cottin, Y., Briot, F., Horiot, J.C. and Rochette, L. (1999) Effect of Combined Irradiation and Doxorubicin Treatmenton Cardiac Function and Antioxidant Defenses in the Rat. Free Radical Biology and Medicine, 26, 785-800.

[26]   Yilmaz, S., Atessahin, A., Sahna, E., Karahan, I. and Ozer, S. (2006) Protective Effect of Lycopene on Adriamycin-Induced Cardiotoxicity and Nephrotoxicity. Toxicology, 218, 164-171.

[27]   Kappus, H. (1987) Oxidative Stress in Chemical Toxicity. Archives of Toxicology, 60,144-149.

[28]   Serrano-Mollar, A., Closa, D., Prats, N., Blesa, S., Martinez-Losa, M., Cortijo, J., Estrela, J.M., Morcillo, E.J. and Bulbena, O. (2003) In Vivo Antioxidant Treatment Protects against Bleomycin-Induced Lung Damage in Rats. British Journal of Pharmacology, 138, 1037-1048.

[29]   Gurujeyalakshmi, G., Wang, Y. and Giri, S.N. (2000) Suppression of Bleomycin-Induced Nitric Oxide Production in Mice by Taurine and Niacin. Nitric Oxide, 4, 399-411.

[30]   Rubbo, H., Radi, R. and Trujillo, M. (1994) Nitric Oxide Regulation of Superoxide and Peroxynitrite-Dependent Lipid Peroxidation. Formation of Novel Nitrogen-Containing Oxidized Lipid derivatives. Journal of Biological Chemistry, 269, 26066-26075.

[31]   Samuni, A.M., DeGraff, W., Krishna, M.C. and Mitchell, J.B. (2002) Nitroxides as Antioxidants: Tempol Protects against EO9 Cytotoxicity. Molecular and Cellular Biochemistry, 234-235, 327-333.

[32]   Thiemermann, C., McDonald, M.C. and Cuzzocrea, S. (2001) The Stable Nitroxide, Tempol, Attenuates the Effects of Peroxynitrite and Oxygen-Derived Free Radicals. Critical Care Medicine, 29, 223-224.

[33]   Thiemermann, C. (2003) Membrane-Permeable Radical Scavengers (Tempol) for Shock, Ischemia-Reperfusion Injury, and Inflammation. Critical Care Medicine, 31, S76-S84.

[34]   Mitchell, J.B., Krishna, M.C., Kuppusamy, P., Cook, J.A. and Russo, A. (2001) Protection against Oxidative Stress by Nitroxides. Experimental Biology andMedicine, 226, 620-621.